2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid

C31H34ClN3O3 — CID 19922895

IUPAC2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid
SMILESCOc1ccc2c(c1)c(CC(=O)O)c(C)n2CCN1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1
InChIInChI=1S/C31H34ClN3O3/c1-22-28(20-31(36)37)29-19-26(38-2)11-12-30(29)35(22)18-17-33-13-15-34(16-14-33)21-24-5-3-4-6-27(24)23-7-9-25(32)10-8-23/h3-12,19H,13-18,20-21H2,1-2H3,(H,36,37)
InChIKeyBXQAYJGMBSXWPO-UHFFFAOYSA-N
MW532.08 g/mol
LogP5.72
Rot. Bonds9

About 2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid

2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid (PubChem CID 19922895) has the molecular formula C31H34ClN3O3 and a molecular weight of 532.08 g/mol. Its IUPAC name is 2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid.

Molecular Properties

Compound Name2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid
PubChem CID19922895
Molecular FormulaC31H34ClN3O3
Molecular Weight532.08 g/mol
Exact Mass531.23
IUPAC Name2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid
SMILESCOc1ccc2c(c1)c(CC(=O)O)c(C)n2CCN1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1
InChIInChI=1S/C31H34ClN3O3/c1-22-28(20-31(36)37)29-19-26(38-2)11-12-30(29)35(22)18-17-33-13-15-34(16-14-33)21-24-5-3-4-6-27(24)23-7-9-25(32)10-8-23/h3-12,19H,13-18,20-21H2,1-2H3,(H,36,37)
InChIKeyBXQAYJGMBSXWPO-UHFFFAOYSA-N
XLogP5.72
TPSA57.94 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds9
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500532.08
LogP ≤ 55.72
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}

Analyze 2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid?
The IUPAC name of 2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid (CID 19922895) is 2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid.
What is the SMILES notation for 2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid?
The canonical SMILES for 2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid is COc1ccc2c(c1)c(CC(=O)O)c(C)n2CCN1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1.
What is the InChIKey of 2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid?
The InChIKey is BXQAYJGMBSXWPO-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H34ClN3O3/c1-22-28(20-31(36)37)29-19-26(38-2)11-12-30(29)35(22)18-17-33-13-15-34(16-14-33)21-24-5-3-4-6-27(24)23-7-9-25(32)10-8-23/h3-12,19H,13-18,20-21H2,1-2H3,(H,36,37).
What are the key properties of 2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid?
2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid has a molecular weight of 532.08 g/mol, XLogP of 5.72, 9 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[1-[2-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethyl]-5-methoxy-2-methylindol-3-yl]acetic acid is sourced from PubChem (CID 19922895), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).